The in vitro binding properties of enterotoxins of Vibrio cholerae and Escherichia coli to different pure gangliosides and related neutral glycosphingolipids were analyzed with a sorbent assay utilizing plastic tubes to which the glycolipid substances had been coupled. It was found that the cholera toxin bound to GM, ganglioside better than to the other tested substances Gm., GM3-NGN, GM2, GD1a, GD1b, 6r, GAI, tetrahexoside-GlcNac and globoside.
INFECT. IMMUNITY tor level. Such competition could be obtained by blocking the active site(s) of' the toxin molecules with free receptor substance or a receptor-analogue. Alternatively, the tissue receptors could be covered with some agent devoid of toxin activity.
The observation by van Heyningen et al. (20) that a ganglioside mixture could inactivate cholera toxin led to the identification by Holmgren et al. (10, 11) of'the possible tissue receptor structure for the cholera enterotoxin. Analyses of' the reactivity of the toxin with various pure gangliosides and neutral glycosphingolipids (10, 11) revealed that the sialidase-resistant ganglioside GN, fixed and inactivated the cholera toxin with an affinity and specificity that indicated that this ganglioside constitutes or at least contains the tissue receptor structure (11) . The GN,u ganglioside can therefore be used as "receptor substance" in studies of' cholera toxin blocking. A natural cholera toxoid which can bind to intestinal mucosal cells (14) showed a similar affinity for GM, ganglioside as the active toxin (11) . This suggested that this toxoid could possibly interfere with the activity of enterotoxins by competing for the same intestinal receptors.
The aim of' the present study was to elucidate whether the cellular binding sites for the enterotoxin of' V. cholerae also function as tissue receptors for E. coli heat-labile enterotoxin. One approach was to compare the binding properties in vitro to various pure glycosphingolipids including the GN, ganglioside and the inactivation of the toxins that may be caused by the contact with such substances. A second approach was to test whether the natural cholera toxoid could interfere with the intestinal secretory response to enterotoxins of' the two bacterial species.
MATERIALS AND METHODS V. cholerae enterotoxin and enterotoxoid. Isolated exo-enterotoxin (choleragen) of V. cholerae (Inaba) was prepared under contract for the National Institute of Allergy and Infectious Diseases (NIAID) by R. A. Finkelstein, Dallas, Texas, as described (5) . The lot number of the preparation was 1071 and the material was provided by NIAID via R. Northrup. R. A. Finkelstein provided isolated natural cholera toxoid (choleragenoid) prepared as described (5) . These freeze-dried materials were dissolved to a 0.2%/c (wt/ vol) solution in sterile tris(hydroxymethyl)aminomethane(Tris) -ethylenediaminetetraacetic acid (EDTA) buffer, pH 7.5 (0.05 M Tris, 0.001 M Na2EDTA, 0.003 M NaN,, and 0.2 M NaCl) and dispensed into portions which were kept in stoppered glass tubes at -20 C until use. Culture filtrates from V. cholerae Inaba and Ogawa bacteria were used as crude cholera enterotoxins. 10 ,m amplitude, in 12-ml batches for 5 min. After 3 h centrif'ugation at 4,000 g, the clear supernatant fluid was f'iltered through 0.65 gm and 0.45-gm (pore size) cellulose acetate filters (Millipore Corp.) and neomycin was added to a f'inal concentration of' 100 ug/ml. The dry weight of' this material was approximately 30 mg/ml.
The enterotoxins from P5 and 853/67 were stored in portions at 20 C until use within 3 months, whereas the other E. coli enterotoxin preparations were lyophilized and kept at 4 C until use up to a year later, when they were dissolved in TG buffer for each test occasion. Two toxin preparations from different cultures were used f'rom strain B2577/67, I and II.
Antisera. Antiserum to cholera toxin was obtained from a rabbit given three subcutaneous injections of 30 gg of the purif'ied toxin without adjuvant 3 weeks apart. Bleeding was performed 2 weeks after the second injection.
Antiserum against enterotoxin from E. coli strain P5 was provided by 0. S6derlind. It was produced in a rabbit given three subcutaneous injections of partially purified enterotoxin 3 weeks apart. Bleeding was perf'ormed 10 days after the last injection.
Glycosphingolipids. L. Svennerholm, Goteborg, Sweden, provided a series of gangliosides and allied neutral glycosphingolipids isolated from human brains with the chromatographic methods recently described (19) . The substances had been analyzed for total neutral sugars, hexosamine, sialic acid, and fatty acids by gas-liquid chromatography (GLC). The positions of glycosidic bonds had been determined by permethylation (6) , and the partially methylated sugars had been converted into alditol acetates and analyzed by GLC and mass spectrometry (1, 2 (7, 12) . Dissolved in TG buffer the following neutral glycosphingolipids and gangliosides were tested for their capacity to react with enterotoxins: globoside, GalNAc#1-3Galacl-4GalB1-4Glc-Cer; GA,, Galfl3GalNAc#1-4Gal#1-4Glc-Cer; tetrahexoside-GlcNAc, Gal,1-4GlcNAc,1-3Gal,1-4Glc-Cer; GMS, NANa2-3Gal#1-4Glc-Cer and NGNa2-3Gal#1-4Glc-Cer; GM2, GalNAc#1-4(NANa2-3)Gal#1-4Glc-Cer; GM,, Gal,81-3GalNAc,B1 -4(NA2 -3)Galf1 -4Glc -Cer; GD1.
NANa2-3Gal#1-3GalNAcf1-4 (NANa2-3)Gal#1-4Glc-Cer; GDSb, Ga1#1-3GalNAcfl1-4(NANa2-8NANa2-3) Gal,1-4Glc-Cer; GT1, NANa2-3Gal,B1-3GalNAcfl1-4(NANa2-8NANca2-3)Gal 1-4Glc-Cer.
(Abbreviations used are: NAN, N-acetylneuraminic acid; NGN, N-glycolylneuraminic acid; Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; GlcNAc, N-acetylglucosamine; Cer, ceramide. The ganglioside nomenclature is according to Svennerholm [18] ).
The purity of the various gangliosides and neutral glycolipids was in general better than 99%, and in the case of GM,S better than 99.9%.
Control reagents. For control purposes purified V. cholerae Inaba lipopolysaccharide (9) , rabbit antiserum to this antigen, and rabbit antiserum to a derivate from Inaba culture filtrate (approximately 10% lipopolysaccharide and 0.1% exo-enterotoxin) were used. Tritiated GM, ganglioside provided by L.
Svennerholm and rabbit antisera reactive with the glycosphingolipids GAS, tetrahexoside-GlcNAc, and globoside were also employed. Double diffusion in gel. A sensitive microplate double diffusion-in-gel method was used for analyses of the capacity of the glycosphingolipids to fix enterotoxins in vitro (11) . In volumes of 25 uliters, 1.2 ug of isolated cholera toxin was tested against glycosphingolipid amounts ranging from 2.5 ng to 10 ug. Similar tests were done with the crude enterotoxins of V. cholerae and E. coli at concentrations of up to 100 mg/ml or, in the case of E. coli P5 and 853/67, with the undiluted lysates. Registration of precipitation lines was done after diffusion for 4 days at room temperature, as well as after staining with Coomassie blue.
ELISA. The enzyme-linked immunosorbent assay (ELISA) technique of Engvall and Perlmann (4), as adapted to cholera serology by Holmgren and Svennerholm (12), was used with minor modifications. Isolated V. cholerae enterotoxin at a concentration of 2 Wg/ml or crude E. coli enterotoxins at one-fifth concentrations of the original lysates was incubated in volumes of 0.5 ml in polystyrene test tubes at 37 C for 3 h to bind the antigens to the inner surface of the tubes. After removal of nonattached antigen by washing with phosphate-buffered saline (PBS) containing 0.05% Tween 20, the tubes were incubated for 6 h at room temperature in a roller drum (60 rpm) with 0.5 ml of dilutions of antiserum in PBS-Tween, whereupon non-antigen-bound material was washed off with PBS-Tween. A 0.5-ml amount of anti-rabbit immunoglobulin (Ig)G conjugated by glutaraldehyde to alkaline phosphatase and diluted to an enzyme concentration of 0.2 ng/ml was then allowed to react with antigen-bound IgG antibodies, the tubes were thoroughly washed, and 1 ml of nitrophenylphosphate (1 mg/ml) was added as substrate. After suitable incubation time, the enzyme-substrate reaction was stopped by addition of 1 N NaOH, and the yellow color obtained was registered spectrophotometrically at 400 nm. Details about the reagents and procedures are given in a previous paper (12) .
Glycosphingolipid sorbent assay (GSA). In 0.5-ml volumes the individual gangliosides and the neutral glycosphingolipids dissolved in TG buffer were coupled to the inner surface of disposable polystyrene tubes (11 by 70 mm) Nunc, Roskilde, Denmark) by mere incubation at 37 C for 4 to 5 h. Nonattached material was then removed by washing three times with PBS-Tween. Enterotoxin diluted in TG buffer was added in a volume of 0.5 ml, and the tubes were incubated at room temperature for 2 h in a roller drum (60 rpm) to permit binding to the glycosphingolipid. After washing three times with PBSTween, bound enterotoxin was demonstrated with a dilution of the anti-cholera toxin antiserum followed by anti-IgG conjugated with alkaline phosphatase, and nitrophenylphosphate as described for the ELISA technique (12) . The extinction values recorded were transformed to extinction change per 100 min (Eloo min).
Toxicity tests. The ileal loop technique and the intradermal test in rabbits were used to study the capacity of the gangliosides and the related neutral glycosphingolipids to inactivate the gut and the skin effects of enterotoxins.
In the loop tests 8-to 12-week-old partially inbred rabbits were used, and five or six loops were arranged in each animal as previously described (8) The technique was elaborated with the GMI ganglioside, isolated cholera toxin, and rabbit antiserum to this toxin. This antiserum had an ELISA IgG antibody titer of 10-4-9; for the GSA it was, when not otherwise specified, used diluted 10-4 0. For coating of the tubes in the GSA it was found that a GM 1 concentration of 2 ,ug/ml gave maximal fixation of the cholera toxin, but 200 ng/ml was almost as efficient when tested with 2 ,g/ml of isolated toxin (Fig. 1) . However, the higher G M 1 concentration permitted detection of lower concentrations of cholera toxin, 630 pg/ml compared to 3.5 ng/ml for an extinction of 1.0 per 100 min (E100 min) as shown in Fig. 2. The enterotoxin of the V. cholerae culture filtrates bound to GN, with a slope similar to that observed with pure toxin (Fig. 2) therefore used in GSA to detect glycosphingolipid-bound E. coli enterotoxin; a serum dilution of 1030 was chosen. It was found that E. coli enterotoxins also showed some binding to GM1 ganglioside (Fig. 2) . However, the binding curves differed much from those observed with V. cholerae enterotoxin by being flatter and requiring more material for demonstrable binding (Fig. 2) .
The binding properties of the isolated enterotoxin of V. cholerae and of the enterotoxin of E. coli 853/67 to a series of pure gangliosides and neutral glycosphingolipids was studied by the GSA and compared with the binding to GM1 (Table 1) . Both enterotoxins bound to GM, better than to any other substance, but at much different levels. Both toxins also showed binding to GDla but differed in their reactivity with GD lb-Gr and GA1. In general, the binding of the cholera toxin to certain substances but not to others was more distinct than was the case for the E. coli enterotoxin.
Inactivation of enterotoxins by glycosphingolipids. The capacity of G M, and the other glycosphingolipids to inactivate the toxicity of V. cholerae enterotoxin in the skin and in the gut (11) was reinvestigated and compared with the effects of these compounds on the E. coli enterotoxins. Figure 3 shows the effect of pure GM1 on isolated cholera toxin and on enterotoxin from E. coli 853/67. The skin manifestations and the ileal loop activity of both toxins were inhibited by this ganglioside.
However, much more GM, was required for a corresponding degree of inactivation of the E. coli toxin than of the cholera toxin, for which approximately 1: 1 molar ratios of GM, to toxin were almost completely inactivating. The inactivation curve was also flatter for the E. coli toxin. Similar inactivation curves by GM1 were found for enterotoxins of other E. coli strains.
The inactivating capacity of a series of other glycosphingolipids on E. coli and V. cholerae enterotoxins was compared with that of GM11. The glycosphingolipid amount required to give half-maximal inhibition of approximately three skin BD and 2 x ED50 ileal loop doses was calculated from curves of the type shown in Fig.  3 . The values are given in Table 2 . Enterotoxins from different strains of E. coli were inactivated by very similar amounts of GM, ganglioside; in the skin test approximately 10,000-fold and in the loop assay 300-fold those required to inactivate the cholera toxin. The GM, ganglioside was approximately 400 times more effective than any other substance in the inactivation of cholera toxin, whereas the GM1 specificity seemed less pronounced for inactivation of E. (Table 2) .
Interference by natural cholera toxoid on the ileal secretory response to enterotoxins. Choleragenoid, a natural cholera toxoid, is almost entirely devoid of toxicity in spite of marked in vitro affinity for the GM, ganglioside (11) and good binding to intestinal mucosal cells (14) . The effect on the ileal loop response to cholera toxin and to enterotoxin from E. coli 853/67 by preincubating the loops with this toxoid for 10 to 15 min was analyzed (Table 3) . It was found that the response to cholera toxin was reduced by equimolar and higher amounts of the toxoid. By contrast, the toxoid caused no _0o-% reduction of the response to the E. coli enterotoxin. DISCUSSION Interference with the binding of bacterial toxins to their tissue receptors leading to inhibition of the toxic manifestations can be effected by blocking the binding site of the toxin with a substance identical to or closely resembling the receptor structure, or by occupying the cellular receptors with an inactive toxin analogue. Previous studies have shown that the monosialoganglioside G M1 probably corresponds to the receptor structure for the cholera toxin, and that a natural cholera toxoid binds to this ganglioside with similar affinity as the active toxin and therefore may be regarded as an inactive cholera toxin analogue (10, 11) . The GM1 ganglioside and the natural cholera toxoid were therefore used in the present study as probes to elucidate whether the intestinal hypersecretion which is caused both by enterotoxin of V. cholerae and by enterotoxin of E. coli is initiated through the binding of these two types of toxins to the same or to different cellular binding sites.
A whole series of pure and structurally defined gangliosides and neutral glycosphingolipids was tested in addition to pure GM1, and not only was inactivation of toxicity measured but also the primary binding of enterotoxins to the glycosphingolipids. These precautions are important to permit evaluation of the specificity and the nature of observed interactions, since tissue lipid extracts devoid of gangliosides can cause a nonspecific inactivation of cholera enterotoxin (J. Holmgren and L. Svennerholm, unpublished results). In this study it was shown that the cholera enterotoxin binds much better than E. coli enterotoxins to the G M1ganglioside, and also that this ganglioside inactivates the cholera toxin much better than the E. coli enterotoxins. The other glycosphingolipids were less effective than G M1 both to bind and to inactivate enterotoxins, but the difference between GM1 and other substances was more distinct for the cholera toxin than for E. coli enterotoxins. From these studies it cannot be stated with certainty whether the binding properties of the E. coli enterotoxins to GM, ganglioside are significant with regard to diarrheogenic action. However, it is noteworthy that GDsa and GA1 bound cholera toxin to a higher extinction value than reached with the GM1-bound E. coli enterotoxins. These substances were approximately 400 and 600 time less efficient than GM, to inactivate the cholera toxin and are not likely to function as receptors for this toxin, which might suggest that the binding of E. coli enterotoxin to GM, is probably pathogenetically insignificant. It is also unlikely that any of the other glycosphingolipids tested would correspond to the functional receptor for E. coli enterotoxin.
Despite affinity similar to that of the cholera toxin for the GM, ganglioside (11) and binding properties similar to those of the toxin to mammalian cell membranes (J. Holmgren, L. Lindholm, and I. Lonnroth, unpublished results), the natural cholera toxoid, choleragenoid, is almost entirely devoid of toxicity. In this study, brief preincubation of ileal loops with the natural toxoid made the loops resistant to the cholera toxin; an inhibitory effect was seen with equimolar and higher amounts of toxoid compared to toxin. These findings suggest that the cholera toxoid, through binding to the same intestinal cell membrane receptors as the cholera toxin, can occupy these sites so that later added toxin cannot bind to the intestinal cells and therefore is incapable to initiate fluid accumulation in the loops. The fact that the toxoid has no toxic activity shows that only the capacity to bind to the receptors for the cholera toxin is not by itself sufficient to activate intestinal cells to hypersecretory processes. In contrast to the cholera toxin, the E. coli enterotoxin tested had full effect in ileal loops preincubated with natural cholera toxoid. This indicates that the functional receptors for the E. tubes in a "receptor-specific" sorbent assay permitted exceptionally sensitive in vitro measurement of cholera enterotoxin. With the immunological detection used, toxin concentrations below 1 ng/ml were measured. It is also possible to quantitate cholera toxin in GM1-coated tubes by means of a radiosorbent modification with iodine-labeled cholera toxin, and a further use of polystyrene coated with GM1 is for affinity chromatography with cholera toxin (unpublished data). It is possible that the latter approach could be useful for purification of E. coli enterotoxins, since these toxins as demonstrated bind to the GM, ganglioside, although with low affinity. An alternative way suggested by this investigation to purify these toxins could be through immunosorbent affinity chromatography using antibodies to the cholera toxin, since such antibodies showed binding to E. coli enterotoxins.
During the preparation of this manuscript independent work by N. F. Pierce was published which also made use of cholera toxoid and of ganglioside to elucidate the intestinal receptors for enterotoxins of V. cholerae and E. coli (15) . The results of the two studies complement each other and provide mutual support for the conclusions reached.
